Dirceu Barbano reappointed head of Brazil's Anvisa
This article was originally published in SRA
Dirceu Barbano has been reappointed director of Brazilian healthcare products regulatory agency Anvisa for a second three-year term. The priorities for Anvisa during Mr Barbano’s tenure will be to make the agency "more efficient without compromising on the rigour that characterises its decision-making". This will be achieved by "improving the regulatory framework [and through] closer dialogue with society", Mr Barbano told the Senate's Social Affairs Commission (CAS), which gave final approval to the appointment. Mr Barbano, a pharmacist, joined Anvisa in October 2008 and has been serving as the agency's director-president since January 2011.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.